Interestingly, treating cancer with Ad-IFNα resulted in higherIFNα concentration in tumors than in systemic circulation (Ohashi et al., 2005), and promoted regression ofnon-treated distant tumors as well, also inducing T-cells and natural killercells recruitment to tumor site (Hara et al.,2007). This evidence concerns the gene IFNA1 and cancer.